YELP Insider Sells 34,325 Shares in 3 Months; 20,325-Share Sale Planned
Rhea-AI Filing Summary
YELP, Inc. notice filed on Form 144 shows a proposed sale of 20,325 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $649,419.54 and an approximate sale date of 09/05/2025. The filing records the acquisition history for the securities: restricted stock, performance shares, and a stock option exercise, with specific lots acquired on 05/20/2024, 08/20/2024 and an option exercise dated 09/05/2025.
The filer also disclosed insider sales during the past three months: 7,000 shares on 08/06/2025 for $236,148.51, 7,000 shares on 07/07/2025 for $245,795.90, and 20,325 shares on 06/06/2025 for $751,252.68. The form includes the standard attestation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider intends to sell 20,325 YELP shares; recent three-month insider sales totaled 34,325 shares.
The Form 144 shows a planned brokered sale of 20,325 common shares valued at $649,419.54 with a targeted execution on 09/05/2025. Acquisition details include restricted stock and performance share grants from 2024 and a stock option exercise dated 09/05/2025. The filing also reports three prior insider sales in the past three months totaling 34,325 shares for gross proceeds of $1,233,197.09. As a disclosure filing under Rule 144, this documents transferability compliance and provides transparency about insider liquidity; the filing itself does not disclose company operational or financial changes.
TL;DR: The filing documents routine insider liquidity actions and includes the required attestation regarding material non-public information.
Details show multiple grant types (restricted stock, performance shares) and a stock option exercise as sources of the securities to be sold. The filer affirms absence of undisclosed material adverse information. This form serves governance and compliance purposes by notifying the market of planned insider sales and the dates/quantity involved; it does not indicate any governance changes or regulatory actions.